The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
The bmi-1 gene was first isolated as an oncogene that cooperates with c-myc in the generation of mouse lymphomas. We subsequently identified Bmi-1 as a transcriptional repressor belonging to the mouse Polycomb group. The Polycomb group comprises an important, conserved set of proteins that are required to maintain stable repression of specific target genes, such as homeobox-cluster genes, during development. In mice, the absence of bmi-1 expression results in neurological defects and severe proliferative defects in lymphoid cells, whereas bmi-1 overexpression induces lymphomas. Here we show that bmi-1-deficient primary mouse embryonic fibroblasts are impaired in progression into the S phase of the cell cycle and undergo premature senescence. In these fibroblasts and in bmi-1-deficient lymphocytes, the expression of the tumour suppressors p16 and p19Arf, which are encoded by ink4a, is raised markedly. Conversely, overexpression of bmi-1 allows fibroblast immortalization, downregulates expression of p16 and p19Arf and, in combination with H-ras, leads to neoplastic transformation. Removal of ink4a dramatically reduces the lymphoid and neurological defects seen in bmi-1-deficient mice, indicating that ink4a is a critical in vivo target for Bmi-1. Our results connect transcriptional repression by Polycomb-group proteins with cell-cycle control and senescence.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although specific mechanisms are as yet unknown, the senescence response appears to result in a reorganization of chromatin, at least some aspects of which require pRB activity (Jacobs et al., 1999; Leung et al., 2001; Bandyopadhyay et al., 2002; Itahana et al., 2003; Narita et al., 2003; Zhang et al., 2003, 2005).”
From Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors (2005) · cites this paper as Jacobs et al., 1999
In the citing paper
“Therefore, p16INK4A mediated senescence can be induced via disruption of PRC1/PRC2 complex components such as CBX7, BMI1 or EZH2 followed by decrease in levels of H3K27me3 (Jacobs et al., 1999; Bracken et al., 2003, 2007; Gil et al., 2004).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“The molecular mechanisms underlying this derepression are not completely understood but have been associated with loss of polycomb group of proteins but independent of p53 (Jacobs et al., 1999; Bracken et al., 2007).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Jacobs et al., 1999
In the citing paper
“Because several studies have established a role for the polycomb group protein Bmi1 in the regulation of p16Ink4a (26–28), we analyzed the levels of Bmi1.”
From Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice (2009) · cites this paper as [27]
In the citing paper
“Overexpression of BMI1 [80], CBX7 [81], or CBX8 [82] results in the direct repression of p16 and senescence delay in human and mouse cells.”
From Mechanisms and Regulation of Cellular Senescence (2021) · cites this paper as [80]
Citations
Cites
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationTumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization
Zindy, F., Eischen, C. M., Randle, D. H., Kamijo, T., Cleveland, J. L., Sherr, C. J., & Roussel, M. F. (1998) · Genes & Development · doi:10.1101/gad.12.15.2424 · Cited by 1,245
Alcorta, D. A., Xiong, Y., Phelps, D., Hannon, G., Beach, D., & Barrett, J. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.13742 · Cited by 1,008
van der Lugt, N. M., Domen, J., Linders, K., van Roon, M., Robanus-Maandag, E., te Riele, H., van der Valk, M., Deschamps, J., Sofroniew, M., & van Lohuizen, M. (1994) · Genes & Development · doi:10.1101/gad.8.7.757 · Cited by 781
Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
van Lohuizen, M., Verbeek, S., Scheljen, B., Wientjens, E., van der Guidon, H., & Berns, A. (1991) · Cell · doi:10.1016/0092-8674(91)90382-9 · Cited by 762
Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer
(1996) · Advances in cancer research · doi:10.1016/s0065-230x(08)60352-8 · Cited by 752
Regulation of p16 CDKN2 Expression and Its Implications for Cell Immortalization and Senescence
Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., & Peters, G. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.3.859 · Cited by 733
Cited by
Items 901–1,000 of 1,001
The Theoretical Basis of Transcriptional Therapy of Cancer: Can It Be Put Into Practice?
Melnick, A. M., Adelson, K. B., & Licht, J. D. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.498 · Cited by 29
Cell Memory and Cancer – The Story of the Trithorax and Polycomb Group Genes
Caldas, C., & Aparicio, S. A. J. R. (1999) · Cancer and Metastasis Reviews · doi:10.1023/a:1006333610078 · Cited by 30
“These results effectively connect transcriptional repression by Bmi-1, a Pc-G protein, with cell-cycle control and senescence and also indicate that overexpression of Bmi-1 might contribute to human cancers that retain wild-type ink4a function [90].”
BackgroundRouhi, L., Ferreiro, J. F., Put, N., Michaux, L., Tousseyn, T., Lefebvre, C., Gardiner, A. C., Kelver, W. D., Demuynck, H., Verschuere, J., et al. (2013) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22088 · Cited by 28
“The BMI1 pathway is poorly understood, but this protein likely contributes to cell cycle regulation and senescence by acting as transcriptional repressor of the INK4A-ARF locus which encodes two tumor suppressors CCND2A and CCND2B (Jacobs et al., 1999a,b; Guney et al., 2006; Silva et al., 2006).”
BackgroundMethodResultInfluentialZhou, Y., Zhang, L., Pan, H., Wang, B., Yan, F., Fang, X., Munnee, K., & Tang, Z. (2015) · PLoS ONE · doi:10.1371/journal.pone.0123208 · Cited by 28
“B lymphoma Mo-MLV insertion region 1 homolog (Bmi1) is a member of the polycomb repressive complex 1 (PRC1) that functions as an epigenetic silencer of many target genes such as Ink4a-arf locus [9].”
BackgroundEZH2 Regulates the Expression of p16 in the Nasopharyngeal Cancer Cells
Zhong, J., Min, L., Huang, H., Li, L., Li, D., Li, J., Ma, Z., & Dai, L. (2013) · Technology in Cancer Research & Treatment · doi:10.7785/tcrt.2012.500315 · Cited by 28
Bmi‐1 is critical for the proliferation and invasiveness of gastric carcinoma cells
Li, W., Li, Y., Tan, Y., Ma, K., & Cui, J. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2009.06045.x · Cited by 28
Neural stem cells, tumour stem cells and brain tumours: Dangerous relationships?
SUTTER, R., Yadırgı, G., & Marino, S. (2007) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2007.07.006 · Cited by 33
Self-citationBiphasic MLL takes helm at cell cycle control: Implications in human mixed lineage leukemia
Liu, H., Takeda, S., Cheng, E. H. Y., & Hsieh, J. J.-D. (2008) · Cell Cycle · doi:10.4161/cc.7.4.5426 · Cited by 28
Zhang, R., Liu, T.-Y., Senju, S., Haruta, M., Hirosawa, N., Suzuki, M., Tatsumi, M., Ueda, N., Maki, H., Nakatsuka, R., et al. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0117 · Cited by 30
“Other than c-Myc, anti-senescence genes such as Bmi-1, Mdm2 and Ezh2 may be indispensable for the continuous proliferation of human ESC or iPSC-derived myeloid cells (34-36).”
BackgroundHeltemes-Harris, L. M., Larson, J. D., Starr, T. K., Hubbard, G. K., Sarver, A. L., Largaespada, D. A., & Farrar, M. A. (2015) · Oncogene · doi:10.1038/onc.2015.405 · Cited by 29
Discovery and progress of direct cardiac reprogramming
Kojima, H., & Ieda, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2466-4 · Cited by 28
Bartucci, M., Hussein, M. S., Huselid, E., Flaherty, K., Patrizii, M., Laddha, S. V., Kui, C., Bigos, R. A., Gilleran, J., El‐Ansary, M., et al. (2017) · Targeted Oncology · doi:10.1007/s11523-017-0501-x · Cited by 28
“Although the most well-established transcriptional target of BMI1 is the INK4A/ARF locus, containing key cell cycle regulators [23], BMI1 also has direct protein-protein interaction effects, for example, BMI1 also suppresses p21 [51].”
BackgroundMicroRNA-203 Induces Apoptosis by TargetingBmi-1in YD-38 Oral Cancer Cells
Kim, J., CHOI, D. W., KIM, C. S., Yu, S., KIM, H.-J., Go, D.-S., Lee, S. A., Moon, S. M., Kim, S.-G., Chun, H. S., et al. (2018) · Anticancer Research · doi:10.21873/anticanres.12618 · Cited by 30
Vora, P., Seyfrid, M., Venugopal, C., Qazi, M. A., Salim, S. K., Isserlin, R., Subapanditha, M., O’Farrell, E., Mahendram, S., Singh, M., et al. (2019) · Journal of Neuro-Oncology · doi:10.1007/s11060-019-03192-1 · Cited by 29
Seipel, K., Messerli, C., Wiedemann, G., Bacher, U., & Pabst, T. (2020) · Leukemia Research · doi:10.1016/j.leukres.2020.106296 · Cited by 28
Kajiume, T., Ohno, N., Sera, Y., Kawahara, Y., Yuge, L., & Kobayashi, M. (2009) · Experimental Hematology · doi:10.1016/j.exphem.2009.04.011 · Cited by 28
“The major bmi1 target is the ink4a/arf locus, and the ink4a gene has been shown to be located downstream of bmi1 [18].”
BackgroundLagresle, C., Gardie, B., Eyquem, S., Fasseu, M., Vieville, J.-C., Pla, M., Sigaux, F., & Bories, J.-C. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.5.2325 · Cited by 28
“ferentiation defects through an as yet unknown mechanism (16).”
BackgroundEpigenetic Regulation of Survivin by Bmi1 Is Cell Type Specific During Corticogenesis and in Gliomas
Acquati, S., Greco, A., Licastro, D., Bhagat, H., Ceric, D., Rossini, Z., Grieve, J., Shaked-Rabi, M., Henriquez, N. V., Brandner, S., et al. (2012) · Stem Cells · doi:10.1002/stem.1274 · Cited by 30
Self-citationNishida, Y., Maeda, A., Chachad, D., Ishizawa, J., Qiu, Y. H., Kornblau, S. M., Kimura, S. H., Andreeff, M., & Kojima, K. (2015) · Cancer Science · doi:10.1111/cas.12833 · Cited by 27
Human Corneal Endothelial Cells Expanded In Vitro Are a Powerful Resource for Tissue Engineering
Liu, Y., Sun, H., Hu, M. S., Zhu, M., Tighe, S. P., Chen, S., Zhang, Y., Su, C., Cai, S., & Guo, P. (2017) · International Journal of Medical Sciences · doi:10.7150/ijms.17624 · Cited by 27
Regulatory Network of ARF in Cancer Development.
Ko, A., Han, S. Y., & Song, J. (2018) · PubMed Central · doi:10.14348/molcells.2018.0100 · Cited by 30
Role of Circular RNAs in the Pathogenesis of Cardiovascular Disease
Li, B., Li, Y., Hu, L., Liu, Y., Zhou, Q., Wang, M., An, Y., & Li, P. (2020) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-019-09912-2 · Cited by 27
Integration of the PRB and P53 Cell Cycle Control Pathways
Stewart, C. L., Soria, A. M., & Hamel, P. A. (2001) · Journal of Neuro-Oncology · doi:10.1023/a:1010615822317 · Cited by 31
“Finally, the Bmi-1 Polycomb-group transcriptional repressor also functions as a negative regulator of ARF (and p16 INK4a ) expression.”
Polycomb group mutants exhibit mitotic defects in syncytial cell cycles of Drosophila embryos
O’Dor, E., Beck, S., & Brock, H. W. (2006) · Developmental Biology · doi:10.1016/j.ydbio.2005.11.015 · Cited by 28
“Bmi1, the mammalian Psc homolog originally identified as an oncogene, is also required for regulating lymphoid cell proliferation via repression of the ink4a tumor suppressor locus (Jacobs et al., 1999).”
BackgroundControllable Expansion of Primary Cardiomyocytes by Reversible Immortalization
Zhang, Y., Nuglozeh, E., Touré, F., Schmidt, A. M., & Vunjak‐Novakovic, G. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.057 · Cited by 27
“…which acts through the binding of retinoblastoma protein (Rb) and p53 (Ali and DeCaprio, 2001), and Bmi-1, which downregulates the p16 and p19 Arf tumor suppressor genes encoded by the ink4a locus (Jacobs et al. , 1999), and is often combined with human telomerase (hTERT) (Hashimoto et al. , 2006).”
Dimri, M., Cho, J., Kang, M., & Dimri, G. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.615179 · Cited by 27
“Since, BMI1 is a major regulator of senescence (16, 17), and its knockdown also induces senescent phenotype (25), it is possible that PLK1 inhibition induces senescence via regulation of BMI1.”
BackgroundJaiswal, A. S., Multani, A. S., Pathak, S., & Narayan, S. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-3 · Cited by 27
“Phenotypically, similar processes can be achieved by accelerating senescence using various DNA-damaging agents such as γ-radiations [5,6], oncogenic stimulations [7,8], and genetic or pharmacological manipulations [9].”
BackgroundAlternative product of the p16/CKDN2A locus connects the Rb and p53 tumor suppressors
James, M. C., & Peters, G. G. (2000) · Springer eBooks · doi:10.1007/978-1-4615-4253-7_7 · Cited by 31
Pang, E., Wong, N., Lai, P. B. S., To, K., Lau, W., & Johnson, P. J. (2001) · Genes Chromosomes and Cancer · doi:10.1002/gcc.1220 · Cited by 27
Perturbations of the Ink4a/Arf gene locus in aflatoxin B1-induced mouse lung tumors
Tam, A. S. M., Devereux, T. R., Patel, A. C., Foley, J. F., Maronpot, R. R., & Massey, T. E. (2003) · Carcinogenesis · doi:10.1093/carcin/24.1.121 · Cited by 28
WANG, T., Chen, T., Niu, H., Li, C., XU, C., Li, Y., Huang, R., Zhao, J., & Wu, S. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2216 · Cited by 26
“BMI1 , a component of the polycomb repressive complex 1, was initially identified as an oncogene that cooperates with c-Myc in inducing lymphomas in double transgenic mice (13).”
Targeting Head and Neck Cancer Stem Cells: Current Advances and Future Challenges
Birkeland, A. C., Owen, J. H. J., & Prince, M. E. (2015) · Journal of Dental Research · doi:10.1177/0022034515601960 · Cited by 27
Bmi-1 induces radioresistance by suppressing senescence in human U87 glioma cells
Ye, L., WANG, C., Yu, G., Jiang, Y., Sun, D., Zhang, Z., Yu, X., Li, X., WEI, W., Liu, P., et al. (2014) · Oncology Letters · doi:10.3892/ol.2014.2606 · Cited by 26
“Bmi-1 negatively controls the expression of the p16 gene (31,32); p16 expression is one of the hallmarks of cellular senescence (33) and inhibits the activity of CDK4, which is the key enzyme in the G 1 -”
Li, C., Yan, H.-C., Fu, H.-L., Xu, G.-F., & Wang, X. (2013) · Journal of Animal Science · doi:10.2527/jas.2013-7048 · Cited by 26
Cooper, A. R., van Doorninck, J., Ji, L., Russell, D., Ladanyi, M., Shimada, H., Krailo, M., Womer, R. B., Hsu, J. H.-R., Thomas, D. G., et al. (2010) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1417 · Cited by 28
“normal and tumor cells via transcriptional silencing the CDKN2A locus (31).”
Tiwari, P., & Gupta, K. P. (2014) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2014.04.020 · Cited by 26
Post-Translational Modifications of Histones in Vertebrate Neurogenesis
Mitrousis, N., Tropepe, V., & Hermanson, O. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00483 · Cited by 29
Rnf2 knockdown reduces cell viability and promotes cell cycle arrest in gastric cancer cells
Zhang, J., Sun, Z., Han, Y., Yao, R., Yue, L., Xu, Y. H., & Zhang, J. (2017) · Oncology Letters · doi:10.3892/ol.2017.5868 · Cited by 27
“In mammals, PRC1 and PRC2 bind to and repress the INK4a/ARF locus, which encodes several proteins involved in cell cycle regulation including p14ARF and p16INK4A (20,21).”
Polycomb-mediated repression of EphrinA5 promotes growth and invasion of glioblastoma
Ricci, B., Millner, T. O., Pomella, N., Zhang, X., Guglielmi, L., Badodi, S., Ceric, D., Gemma, C., Cognolato, E., Zhang, Y., et al. (2020) · Oncogene · doi:10.1038/s41388-020-1161-3 · Cited by 27
“These actions are, at least in part, mediated through transcriptional repression of the ink4a locus, encoding for p16 and p19 [6], and of the cell cycle inhibitor p21 [9, 10].”
BackgroundSelf-citationPolycomb Group Protein Bmi1 Promotes Hematopoietic Cell Development from Embryonic Stem Cells
Ding, X., Lin, Q., Enseñat‐Waser, R., Rose‐John, S., & Zenke, M. (2011) · Stem Cells and Development · doi:10.1089/scd.2010.0539 · Cited by 28
“Bmi1 activity in maintaining the pool of adult stem cells is mainly due to repression of the Ink4a/Arf locus, which encodes inhibitors of the cell cycle kinase p16Ink4a and p19Arf [18,19,23,24].”
Stage-specific Arf tumor suppression in Notch1-induced T-cell acute lymphoblastic leukemia
Volanakis, E. J., Williams, R. T., & Sherr, C. J. (2009) · Blood · doi:10.1182/blood-2009-07-233346 · Cited by 27
Role of DMP1 and its future in lung cancer diagnostics
Sugiyama, T., Frazier, D. P., Taneja, P., Morgan, R. L., Willingham, M. C., & Inoue, K. (2008) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.8.4.435 · Cited by 28
The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D’Amico, M., Wu, K., Vizio, D. D., Reutens, A. T., Stahl, M. C., Fu, M., Albanese, C., Russell, R. G., Muller, W. J., White, M. A., et al. (2003) · PubMed · Cited by 28
Self-citationThe elements of stem cell self-renewal: a genetic perspective
Pazianos, G., Uqoezwa, M., & Reya, T. (2003) · BioTechniques · doi:10.2144/03356ss03 · Cited by 26
Ip, J. C. Y., Pang, T., Glover, A. R., Soon, P. S. H., Zhao, J., Clarke, S. J., Robinson, B. G., Gill, A. J., & Sidhu, S. B. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0392 · Cited by 29
Post-Translational Regulation of ARF: Perspective in Cancer
Seo, J., Seong, D., Lee, S. R., Oh, D., & Song, J. (2020) · Biomolecules · doi:10.3390/biom10081143 · Cited by 28
“Bmi-1-deficient cells showed cellular senescence phenotypes, including decreased cell proliferation, defective S-phase cell cycle, cytoplasmic enlargement, unresponsiveness to growth factors, and increased acidic β-galactosidase, indicating that Bmi-1 deficiency was closely related to cellular senescence [57].”
BackgroundMesenchymal Stem Cell Senescence and Osteogenesis
Tjempakasari, A., Suroto, H., & Santoso, D. (2021) · Medicina · doi:10.3390/medicina58010061 · Cited by 29
“ROS levels rise after various types of stress, including chemotherapy drugs, loss of telomere defenses, DNA damage, and oncogene activation [39,43].”
BackgroundA state-of-the-art review on the MicroRNAs roles in hematopoietic stem cell aging and longevity
Ortiz, G. G. R., Mohammadi, Y., Nazari, A., Ataeinaeini, M., Kazemi, P., Yasamineh, S., Al-Naqeeb, B. Z. T., Zaidan, H. K., & Gholizadeh, O. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01117-0 · Cited by 28
Agarwal, P., Kabir, F. M. L., DeInnocentes, P., & Curtis, R. (2012) · InTech eBooks · doi:10.5772/27882 · Cited by 32
Sulman, E. P., Aldape, K. D., & Colman, H. (2008) · Current Problems in Cancer · doi:10.1016/j.currproblcancer.2008.02.004 · Cited by 29
Cyclin E1 is a common target of BMI1 and MYCN and a prognostic marker for neuroblastoma progression
Mao, L., Ding, J., Perdue, A., Yang, L., Zha, Y., Ren, M., Huang, S., Cui, H., & Ding, H.-F. (2011) · Oncogene · doi:10.1038/onc.2011.536 · Cited by 26
“It has been shown previously that BMI1 can promote cell survival by suppressing apoptosis (Jacobs et al 1999b, Yamashita et al 2008).”
BackgroundInfluentialYip, Y., Tsang, C., Deng, W., Cheung, P.-Y. P., Jin, Y., Cheung, A. L. M., Lung, M. L., & Tsao, S. (2010) · Journal of Medical Virology · doi:10.1002/jmv.21875 · Cited by 29
“Bmi-1 is a transcriptional repressor isolated as an oncogene in mouse B cell lymphomas [Jacobs et al., 1999a].”
BackgroundGjerstorff, M. F., Relster, M. M., Greve, K. B. V., Moeller, J. B., Eliáš, D., Lindgreen, J., Schmidt, S., Mollenhauer, J., Voldborg, B. G. R., Pedersen, C. B., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku852 · Cited by 25
Cancerous stem cells: deviant stem cells with cancer-causing misbehavior
Chandler, J. M., & Lagasse, E. (2010) · Stem Cell Research & Therapy · doi:10.1186/scrt13 · Cited by 29
Wang, R., Xue, X., Wang, Y., Zhao, H., Zhang, Y., Wang, H., & Miao, D. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.30488 · Cited by 26
“BMI1 deficiency causes a generalized failure-tothrive and a significant shortening of lifespan [21, 22].”
miR-200c Modulates the Pathogenesis of Radiation-Induced Oral Mucositis
Tao, J., Fan, M., Zhou, D., Hong, Y., Zhang, J., Liu, H., Sharma, S. P., Wang, G., & Dong, Q. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/2352079 · Cited by 28
“Bmi-1 inhibits senescence and extends the lifespan of normal cells by suppressing p16 [45].”
BackgroundSkeletal muscle cell transplantation: models and methods
Mueller, A. L., & Bloch, R. J. (2019) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-019-09550-w · Cited by 25
Bmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension
Li, K., Li, Y., Yu, Y., Ding, J., Huang, H., Chu, C., Hu, L., Yu, Y., Cao, Y. Z., Xu, P., et al. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01439-0 · Cited by 25
“To explore the mechanism of fibroblast senescence, we focused on Bmi-1, which is a proto-oncogene that mainly mediates oxidative stress and DDR, cell self-renewal, and senescence [20, 25, 26].”
BackgroundTschan, M. P., Federzoni, E. A., Haimovici, A., Britschgi, C., Moser, B. A., Jin, J., Reddy, V. A., Sheeter, D. A., Fischer, K. M., Sun, P., et al. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.07.009 · Cited by 26
Bmi-1 confers adaptive radioresistance to KYSE-150R esophageal carcinoma cells
Wang, G., Liu, L., Sharma, S. P., Liu, H., Yang, W., Sun, X., & Dong, Q. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.087 · Cited by 25
Knockdown BMI1 expression inhibits proliferation and invasion in human bladder cancer T24 cells
Liang, W., Zhu, D., Cui, X., Su, J., Liu, H., Han, J., Zhao, F., & Xie, W. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1745-0 · Cited by 25
Neuro-Muscular Differentiation of Adult Porcine Skin Derived Stem Cell-Like Cells
Lermen, D., Gorjup, E., Dyce, P. W., von Briesen, H., & Müller, P. F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008968 · Cited by 30
“It contributes to the maintenance of stem cell related properties via the repression of p16, p19 and p53, all related to the process of cellular senescence [50–54].”
BackgroundGenetic regulation of thymocyte progenitor aging
Berent-Maoz, B., Montecino-Rodriguez, E., & Dorshkind, K. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.04.006 · Cited by 23
Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma
Lu, Y.-W., Li, J., & Guo, W. (2010) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-29-143 · Cited by 26
Apoptosis resistance and response to chemotherapy in primary nodal diffuse large B‐cell lymphoma
Muris, J. J. F., Meijer, C. J. L. M., Ossenkoppele, G. J., Vos, W., & Oudejans, J. J. (2006) · Hematological Oncology · doi:10.1002/hon.774 · Cited by 27
Errors in Erasure: Links Between Histone Lysine Methylation Removal and Disease
Duncan, E. M., & Allis, C. D. (2010) · Springer eBooks · doi:10.1007/978-3-7643-8989-5_4 · Cited by 27
Bmi-1 over-expression plays a secondary role in chronic myeloid leukemia transformation
Merkerová, M. D., Votavová, H., Kračmarová, A., Klamová, H., & Brdička, R. (2007) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190601186002 · Cited by 24
“On the contrary, Bmi-1 overexpression reduces INK4a expression and immortalizes the fibroblasts [1].”
BackgroundMinamide, R., Fujiwara, K., Hasegawa, K., & Yoshikawa, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084460 · Cited by 26
“Because Bmi1 downregulates the expression of p19 mRNA [29,30] and p21 mRNA [31,32] in NPCs, we quantified these mRNA levels in necdin-null NPCs (Fig.”
BackgroundXu, N., Li, Y., Li, X., Zhou, X., Cao, R., Li, H., Li, L., Lu, Z., Huang, J., Fan, Z., et al. (2016) · Journal of Hematology & Oncology · doi:10.1186/s13045-016-0270-5 · Cited by 24
MOZ and BMI1 act synergistically to maintain hematopoietic stem cells
Sheikh, B. N., Metcalf, D., Voss, A. K., & Thomas, T. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.10.006 · Cited by 24
Structural heterogeneity of the mammalian polycomb repressor complex in immune regulation
Kang, S. J., & Chun, T. (2020) · Experimental & Molecular Medicine · doi:10.1038/s12276-020-0462-5 · Cited by 25
Vogel, T., Stoykova, A., & Gruß, P. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20876 · Cited by 24
“…has been shown in other systems than the brain: e.g., growth stimulation has been shown for RING1A (Satijn and Otte 1999b), M33 (Core et al., 1997), and Bmi1 (Jacobs et al., 1999; Leung et al., 2004); growth inhibition has been shown for Mel-18 and hPc2 (Satijn et al., 1997; Tetsu et al., 1998).”
BackgroundMethodInfluentialNuclear Translocation of Mouse Polycomb M33 Protein in Regenerating Liver
Noguchi, K., Shiurba, R., & Higashinakagawa, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6480 · Cited by 24
Wang, Y., Xu, Q., Sack, L. M., Kang, C., & Elledge, S. J. (2016) · Genes & Development · doi:10.1101/gad.271445.115 · Cited by 24
“is epigenetically silenced in certain fibroblast cell lines [62] and is activated when triggered by senescence stimuli, unsurprisingly multiple transcription and epigenetic regulation are involved in p16 activation [63-70].”
BackgroundChen, Y., Lian, G., Ou, G., Yang, K., Chen, J., Li, H., Chen, S., Li, J., Zeng, L., & Huang, K. (2015) · Gastric Cancer · doi:10.1007/s10120-015-0485-0 · Cited by 23
“Its effects on tumorigenesis involve repression of the Ink4a-Arf locus, which is an essential cell cycle regulator and encodes p16 and p19arf [7].”
BackgroundNojima, I., Hosoda, R., Toda, Y., Saito, Y., Ueda, N., Horimoto, K., Iwahara, N., Horio, Y., & Kuno, A. (2022) · Aging · doi:10.18632/aging.203999 · Cited by 23
“Gene Forward Reverse Mouse Cdkn2a (p16) 5'-ATCTGGAGCAGCATGGAGTC-3' 5'-GGGGTACGACCGAAAGAGTT-3' Cdkn2a (p19) 5'-GCTCTGGCTTTCGTGAACAT-3' 5'-TCGAATCTGCACCGTAGTTGAG-3' Cdkn1a (p21) 5'-TCCACAGCGATATCCAGACA-3' 5'-GGACATCACCAGGATTGGAC-3' Igfbp1 5'-CTGCCAAACTGCAACAAGAA-3' 5'-ACACCAGCAGAGTCCAGCTT-3' Igfbp2 5'-TGGAGGAGTTCCCAGTTT…”
BackgroundInfluentialSenescence plays a role in myotonic dystrophy type 1
García-Puga, M., Saenz‐Antoñanzas, A., Gereñu, G., Arrieta-Legorburu, A., Fernández‐Torrón, R., Zulaica, M., Sáenz, A., Elizazu, J., Nogales‐Gadea, G., Gadalla, S. M., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.159357 · Cited by 24
“Additionally, BMI1, a member of the Polycomb family that plays a role in cell proliferation and senescence through the repression of p16INK4A, ARF, and p21CIP1 (41, 42), showed significantly reduced expression in DM1 fibroblasts (Figure 4K).”
BackgroundMohty, M., Szydlo, R., Yong, A. S. M., Apperley, J. F., Goldman, J. M., & Melo, J. V. (2008) · Blood · doi:10.1182/blood-2008-04-148130 · Cited by 23
Chromatin methylation and cardiovascular aging
Illi, B., Ciarapica, R., & Capogrossi, M. C. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.011 · Cited by 23
“H3k27me3 [173].”
Gu, Z., Liu, Y., Zhang, Y., Jin, S., Chen, Q., Goltzman, D., Karaplis, A. C., & Miao, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041542 · Cited by 23
“In view of the fact that decreased cell proliferation and increased cell apoptosis are often mediated by upregulated expression of cyclin dependent kinase inhibitors (CDKIs) [19,20], we examined p16, p21, p27 and p53 protein expression as well as protein expression of the oncogene Bmi-1, a member of the Polycomb/trith…”
BackgroundChoy, B., Bandla, S., Xia, Y., Tan, D., Pennathur, A., Luketich, J. D., Godfrey, T. E., Peters, J. H., Sun, J., & Zhou, Z. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-146 · Cited by 24
“It functions as a transcriptional repressor through chromatin modification and plays a role in axial patterning, cell cycle regulation, hematopoiesis, and senescence [11,12].”
BackgroundPaolicchi, E., Pacetti, P., Giovannetti, E., Mambrini, A., Orlandi, M., Crea, F., Romani, A. A., Tartarini, R., Danesi, R., Peters, G. J., et al. (2013) · Oncology Letters · doi:10.3892/ol.2013.1559 · Cited by 25
“Previous studies have demonstrated that EZH2 contributes to the epigenetic silencing of several target genes that control cell growth and proliferation, including E-cadherin, Rb and p16 (18).”
The knock-down of overexpressed EZH2 and BMI-1 does not prevent osteosarcoma growth
Setoguchi (2010) · Oncology Reports · doi:10.3892/or_00000684 · Cited by 24
Neault, M., Couteau, F., Bonneau, É., Guire, V. D., & Mallette, F. A. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.04.001 · Cited by 23
Yoshitake, Y., Howard, T. L., Christian, J. L., & Hollenberg, S. M. (1999) · Developmental Biology · doi:10.1006/dbio.1999.9473 · Cited by 23
Senescence as a modulator of oral squamous cell carcinoma development
Parkinson, E. K. (2010) · Oral Oncology · doi:10.1016/j.oraloncology.2009.09.009 · Cited by 25
Dobrzycka, K. M., Kang, K., Jiang, S., Meyer, R., Rao, P. H., Lee, A. V., & Oesterreich, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1381 · Cited by 26
“RT-PCR analysis revealed that there was no difference in expression of Bmi-1 and CBX7; however, TBX2 was significantly increased in SAFB1 / MEFs (Fig.”
BackgroundInfluentialMacDonald, J. A., Bradshaw, G. A., Jochems, F., Bernards, R., & Letai, A. G. (2025) · Cell Death and Differentiation · doi:10.1038/s41418-024-01431-1 · Cited by 27
Liu, T. M., Tew, W., Yang, Z., Lim, B., Hui, J. H. P., Lee, E. H., Loh, Y., & Cool, S. M. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-08094-x · Cited by 25
“BMI1 promotes cell cycle progression and regulates senescence by acting as a transcriptional repressor at the INK4a/ARF locus [58].”
Cho, K.-W., Andrade, M., Bae, S., Kim, S., Kim, J. E., Jang, E. Y., Lee, S., Husain, A., Sutliff, R. L., Calvert, J. W., et al. (2023) · Circulation · doi:10.1161/circulationaha.122.061131 · Cited by 22
PRC1 directs PRC2-H3K27me3 deposition to shield adult spermatogonial stem cells from differentiation
Hu, M., Yeh, Y.-H., Maezawa, S., Nakagawa, T., Yoshida, S., & Namekawa, S. H. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad1203 · Cited by 24
“This feature is unique to A undiff because PRC1 positively regulates the cell cycle in somatic cells by suppressing the major cell cycle inhibitor Cdkn2a gene, and the loss of PcG-related functions leads to cell cycle inhibition ( 105 ,106 ).”
BackgroundZheng, X., Wang, Y.-F., Liu, B., Liu, C., Liu, D., Zhu, J., Yang, C., Yan, J., Liao, X., Meng, X., et al. (2014) · Nucleic Acid Therapeutics · doi:10.1089/nat.2013.0459 · Cited by 22
“Previous studies have indicated that the Bmi-1 gene regulates cell proliferation and senescence mainly though the INK4a locus (Jacobs et al., 1999).”
BackgroundEpigenetic Mechanisms in Penile Carcinoma
Kuasne, H., Marchi, F. A., Rogatto, S. R., & Cólus, I. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140610791 · Cited by 22
miR-300 mediates Bmi1 function and regulates differentiation in primitive cardiac progenitors
Cruz, F. M., Tomé, M., Bernal, J. A., & Bernad, A. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.255 · Cited by 22
“Overexpression of Bmi1 results in repression of the tumor suppressor p16INK4a, which has emerged as a major regulator of aging and age-associated pathologies.(44) We show that in CPCs,Bmi1, andmiR-300 oppositely regulate expression of p16Ink4a and p19ARF.”
BackgroundHoffmann, M. J., Dehn, J., Droop, J., Niegisch, G., Niedworok, C., Szarvas, T., & Schulz, W. A. (2015) · Non-Coding RNA · doi:10.3390/ncrna1030266 · Cited by 23
Pharmacological targets of breast cancer stem cells: a review
Pindiprolu, S. K. S. S., Krishnamurthy, P. T., & Chintamaneni, P. K. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1479-3 · Cited by 24
Transcriptional regulation of INK4/ARF locus by cis and trans mechanisms
Farooq, U., & Notani, D. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.948351 · Cited by 26
Bmi-1 Regulates Extensive Erythroid Self-Renewal
Kim, A. R., Olsen, J., England, S. J., Huang, Y.-S., Fegan, K. H., Delgadillo, L. F., McGrath, K. E., Kingsley, P. D., Waugh, R. E., & Palis, J. (2015) · Stem Cell Reports · doi:10.1016/j.stemcr.2015.05.003 · Cited by 22
“Bmi-1 regulates the self-renewal of several adult stem cell populations, including hematopoietic, neural, and cancer stem cells, often through repression of p16/p19 (Jacobs et al., 1999; Park et al., 2003; Molofsky et al., 2003; Kreso et al., 2014).”
BackgroundmiR-203 inhibits cell growth and regulates G1/S transition by targeting Bmi-1 in myeloma cells
Wu, S., Niu, W.-Y., Li, Y.-P., Huang, H.-B., & Zhan, R. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2016.5832 · Cited by 22
Kameda-Smith, M. M., Zhu, H., Luo, E.-C., Suk, Y., Xella, A., Yee, B., Chokshi, C., Xing, S., Tan, F., Fox, R. G., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-35118-3 · Cited by 7
Metadata
- Authors
- Jacobs, J. J. L., Kieboom, K., Marino, S., DePinho, R. A., & van Lohuizen, M.
- Affiliations
- The Netherlands Cancer Institute (NL)
- Harvard University (US)
- Venue
- Nature
- Published
- 1999-01
- Volume
- 397
- Issue
- 6715
- Pages
- 164-168
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1481473039
- Cited by
- 1,580
- References
- 30
- Citations by year
- 2026: 12 · 2025: 15 · 2024: 24 · 2023: 29 · 2022: 36 · 2021: 36 · 2020: 42 · 2019: 43 · 2018: 42 · 2017: 53 · 2016: 71 · 2015: 76 · 2014: 76 · 2013: 76 · 2012: 86
- FWCI
- 16.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- National Institute of Neurological Disorders and Stroke
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Keywords
- BMI1, Polycomb group proteins, p16, p19ARF, cellular senescence, cell proliferation, cell cycle progression, S phase, transcriptional repression, lymphoma, lymphoid cells, neurological deficit, H-Ras, oncogenic transformation, tumor suppressor
- MeSH terms
- Animals, Cell Cycle, Cell Division, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Humans, Nuclear Proteins, Oncogenes, Proteins, Proto-Oncogene Proteins, Repressor Proteins, Genes, Tumor Suppressor, Cellular Senescence, Mice, Knockout, Cyclin-Dependent Kinase Inhibitor p16, Tumor Suppressor Protein p14ARF, Mice, Polycomb Repressive Complex 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.